ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Antigen loading
Australian State/Territory : VIC
Clear All
Filter by Field of Research
Clinical chemistry (incl. diagnostics) (3)
Cellular Immunology (2)
Clinical sciences not elsewhere classified (1)
Epigenetics (incl. Genome Methylation and Epigenomics) (1)
Medical and Health Sciences (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (10)
Filter by Status
Closed (9)
Filter by Scheme
NHMRC Project Grants (4)
Project Grants (2)
Career Development Fellowships (1)
Ideas Grants (1)
Programs (1)
Research Fellowships (1)
Filter by Country
Australia (10)
Filter by Australian State/Territory
VIC (10)
WA (4)
ACT (1)
  • Researchers (0)
  • Funded Activities (10)
  • Organisations (0)
  • Funded Activity

    Autoimmunity To Nuclear Antigens

    Funder
    National Health and Medical Research Council
    Funding Amount
    $298,988.00
    More information
    Funded Activity

    Structural Assembly Of Mhc Class I Molecules And The Basis Of T Cell Allorecognition

    Funder
    National Health and Medical Research Council
    Funding Amount
    $335,895.00
    More information
    Funded Activity

    The Role Of Non-classical MHC Class I Molecules In Adaptive Immunity

    Funder
    National Health and Medical Research Council
    Funding Amount
    $443,834.00
    Summary
    Specialised proteins called MHC class Ia molecules (MHC-Ia) stimulate killer T cells to lyse virus infected cells. In contrast, the function of the closely related MHC-Ib is uncertain. Recent findings have demonstrated that MHC-Ib can also be recognised by T cells and this interaction is important in the control of viral infections. However, despite the similarity to MHC-Ia, it is unclear how this interaction occurs. This project aims to investigate how killer T cells recognise MHC-Ib molecules.
    More information
    Funded Activity

    Methylation Sensitive Genes And The Transition To Allergic Disease: A Twin Study

    Funder
    National Health and Medical Research Council
    Funding Amount
    $493,843.00
    Summary
    Australia has amongst the highest reported prevalence allergic conditions (including asthma) in the world. Despite this, little is known about how these conditions arise. Mounting evidence implicates environmentally induced disruption of the genetic blueprint via a process known as epigenetics. We are combining the strengths of a unique collection of identical twins where one of a pair is sensitive to house dust mite, with cutting edge genomics, to characterise the pathways leading to allergy in .... Australia has amongst the highest reported prevalence allergic conditions (including asthma) in the world. Despite this, little is known about how these conditions arise. Mounting evidence implicates environmentally induced disruption of the genetic blueprint via a process known as epigenetics. We are combining the strengths of a unique collection of identical twins where one of a pair is sensitive to house dust mite, with cutting edge genomics, to characterise the pathways leading to allergy in children.
    Read more Read less
    More information
    Funded Activity

    Programming Dendritic Cell Differentiation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,093,315.00
    Summary
    Dendritic cells are essential components of our immune systems. They are located throughout our body and provide the first line of defence against invading microbes. Dendritic cells sense the invader and send out signals to recruit our immune cells to the site of infection. Our research aims to understand how our dendritic cell network is set up and how it functions to promote our immune health.
    More information
    Funded Activity

    Research Fellowship

    Funder
    National Health and Medical Research Council
    Funding Amount
    $847,490.00
    Summary
    Antigen-presenting cells control immune responses. Different types of these cells do different jobs and affect different diseases. We wish to control these processes by determining how the cells live and die. In particular we are interested in controlling the local immune responses during rejection of islet transplantation, which can cure type 1 diabetes.
    More information
    Funded Activity

    Functional Suicide Of Selected Dendritic Cells By Cytochrome C: An In Vivo Model Lacking Cross-presentation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $597,476.00
    Summary
    Certain white blood cells (dendritic cells) activate the immune system, especially its T cells. Infection of such cells elicits killer T cell responses. However not all infections infect dendritic cells. In such cases, the infectious material is eaten by dendritic cells and moved to certain areas within the cell. This process is called cross-presentation and how important it is during various diseases remains moot. We now have a model of testing this by eliminating these cross-presenting cells.
    More information
    Funded Activity

    Antigen Presentatiion, Recognition And The Immune Response

    Funder
    National Health and Medical Research Council
    Funding Amount
    $7,822,981.00
    More information
    Funded Activity

    The Mezzanine T Cell Response: Intervening At The Coal Face

    Funder
    National Health and Medical Research Council
    Funding Amount
    $765,585.00
    Summary
    In an initial immune response, specialised cells in lymph nodes tell T cells to multiply; the stimulated T cells depart and enter target tissue (e.g. lung in the case of flu). We describe a new response whereby the target tissue itself can tell T cells to multiply further. This response in target tissues reveals a new way of altering immune responses. This is especially important as in many diseases, the primary lymph node response has already occurred, so cannot be therapeutically intervened.
    More information
    Funded Activity

    Antigen Selection In The MHC-restricted Cellular Immune Response

    Funder
    National Health and Medical Research Council
    Funding Amount
    $175,570.00
    Summary
    The body's white cells eliminate microorganisms through the actions of immune lymphocytes and other cells which conspire to kill and neutralise these unwanted guests. When microorganisms hide inside the cells of the body they are still detected by a set of T lymphocytes which have specific receptors for scrutinising the surface of cells for any changes which might signal an intracellular infection. The immune system is ever vigilant in its search for signs of infection which are generally appare .... The body's white cells eliminate microorganisms through the actions of immune lymphocytes and other cells which conspire to kill and neutralise these unwanted guests. When microorganisms hide inside the cells of the body they are still detected by a set of T lymphocytes which have specific receptors for scrutinising the surface of cells for any changes which might signal an intracellular infection. The immune system is ever vigilant in its search for signs of infection which are generally apparent when molecules called antigens are released by microorganisms and captured by the body's cells. This activates lymphocytes resulting in an immune response capable of eliminating the microorganisms. Scrutiny of the body's cells by lymphocytes occurs continuously even when there is no infection present in the body. Following infection of a cell, microbial antigens reveal the infection by their appearance on the cell surface where they are detected by the immune system's lymphocytes. This occurs through a mechanism called antigen presentation. During antigen presentation the proteins inside the cell, including those of any invading microorganism, are first degraded into shorter molecules called peptides. This event is called antigen processing. A fraction of the peptides created by antigen processing are captured by specialised receptors present on all cells. These receptors are called HLA or histocompatibility molecules. This project examines the molecular events which mediate the capture of peptide antigens by HLA molecules. The main focus is on those peptide antigens which elicit killer T cell responses by the immune system. A knowledge of how these peptides are selected for presentation and how they are captured and carried to the cell surface is fundamental to understanding immune responses to microorganisms, tumours, allergens, transplants and self tissues as in autoimmunity. Therefore the study is of great general relevance.
    Read more Read less
    More information

    Showing 1-10 of 10 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback